Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin
Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc
S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
HZNP announced its intent to acquire Viela Bio which is a biotech company with a mid-stage biologics pipeline in auto-immune and inflammatory conditions. Viela Bio recently (June 2020) launched Uplinza (anti-CD19 antibody) in the US for NMOSD (rare ocular disorder). Viela Bio's platform of three unique biologic molecules with 9 potential indications as drivers for...
$HZNP is projected with a bullish outlook after a positive earning release, the PEAD projected a bullish outlook for the stock as price is currently trading on the upper boundary of the PEAD cone. If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
Key level Head and shoulders formed. if it ends today the day on the negative it could be going to a target of 64.88. otherwise, if it ends the day positive it is not a head and shoulders confirmed.
Citigroup upgrade sell target to $112 as of August 27th 2020. I have targets just under $100 and again at $125+
Winner! Up 16% AFTER earnings! Buy what's going up after earnings and hold till the next ER!
Hey guys, HORIZON THERAPEUTICS is at the top of the balance area, large volume of sales executed, possibility of breaking this and the next! Please LIKE & FOLLOW, thank you!
Hey guys, HORIZON THERAPEUTICS is at the top of the balance area, large volume of sales executed, possibility of breaking this and the next! Please LIKE & FOLLOW, thank you!
This company is likely to have a major fail and or fall with the rest of the market. getting short positions ready after one new wave up.
About Horizon Therapeutics Horizon Therapeutics(ticker: HZNP) is a biopharmaceutical company that focuses on researching, developing, and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally. It has collaboration agreements with Alliance for Lupus Research, Syneos Health, Inc., and...
Horizon Pharma HZNP – belongs to the medical industry. Shares of HZNP jumped 36.7% this year compared to the decline of 1.9% of the sector. HZNP has recently been working on expanding its marketed pharmaceuticals - Procisbee, Actimona and Revicetti, in addition, in July of this year the company announced the FDA's acceptance of its new drug application. Level 28...
After a blowout beat last Q HZNP is set to release earning on Aug 8th